Role of the renin–angiotensin–aldosterone and kinin–kallikrein systems in the cardiovascular complications of COVID-19 and long COVID

SL Cooper, E Boyle, SR Jefferson, CRA Heslop… - International Journal of …, 2021 - mdpi.com
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the virus responsible
for the COVID-19 pandemic. Patients may present as asymptomatic or demonstrate mild to …

The use of renin–angiotensin–aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID‐19 patients: a systematic review …

Y Wang, B Chen, Y Li, L Zhang, Y Wang… - Journal of medical …, 2021 - Wiley Online Library
Renin–angiotensin–aldosterone system (RAAS) inhibitors, including angiotensin‐converting
enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are one of the most …

Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies

WH Faour, A Choaib, E Issa, FE Choueiry… - Inflammation …, 2022 - Springer
The COVID-19 pandemic created a worldwide debilitating health crisis with the entire
humanity suffering from the deleterious effects associated with the high infectivity and …

Immunological aspects of SARS-CoV-2 infection and the putative beneficial role of vitamin-D

MY Peng, WC Liu, JQ Zheng, CL Lu, YC Hou… - International journal of …, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) is still an ongoing global health crisis. Immediately after the …

COVID-19: yet another coronavirus challenge in transplantation

S Aslam, MR Mehra - The Journal of Heart and Lung Transplantation, 2020 - jhltonline.org
A novel coronavirus, severe acute respiratory syndrome− coronavirus-2 (SARS-CoV-2),
causing a severe acute respiratory syndrome with its disease designated as COVID-19 …

SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention

IS Mahmoud, YB Jarrar, W Alshaer, S Ismail - Biochimie, 2020 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new viral disease that
has gained global attention owing to its ability to provoke community and health-care …

[HTML][HTML] COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management

Y Sattar, W Ullah, H Rauf, S Yadav, M Chowdhury… - IJC Heart & …, 2020 - Elsevier
Abstract Coronavirus Disease 2019 (COVID-19) is a rapidly progressing global pandemic
that may present with a variety of cardiac manifestations including, but not limited to …

COVID‐19, microthromboses, inflammation, and platelet activating factor

C Demopoulos, S Antonopoulou, TC Theoharides - Biofactors, 2020 - Wiley Online Library
Recent articles report elevated markers of coagulation, endothelial injury, and
microthromboses in lungs from deceased COVID‐19 patients. However, there has been no …

Coronavirus disease 2019 (COVID‐19) update: From metabolic reprogramming to immunometabolism

M Rudiansyah, SA Jasim… - Journal of Medical …, 2022 - Wiley Online Library
The field of immunometabolism investigates and describes the effects of metabolic rewiring
in immune cells throughout activation and the fates of these cells. Recently, it has been …

The perfect storm: COVID-19 health disparities in US Blacks

N Phillips, IW Park, JR Robinson, HP Jones - Journal of racial and ethnic …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) accounts for over 180,000 deaths in the
USA. Although COVID-19 affects all racial ethnicities, non-Hispanic Blacks have the highest …